Model
Edge
Ultragenyx Pharmaceutical Inc.
0001713070
Filing Type
4
Filing Date
6/19/2024
Updated
6/20/24, 12:22 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership